Halozyme Therapeutics | HALO - Net Income

Halozyme Therapeutics reported $57.7M in Net Income for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -41725000 14.54M
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Alnylam Pharmaceuticals ALNY:US USD -207493000 198.43M
Amarin AMRN:US USD -5140000 64.82M
Amgen AMGN:US USD 1.62B 527M
Aptinyx Inc APTX:US USD -15303000 2.36M
Baxter International BAX:US USD 181M 3.12B
Cara Therapeutics CARA:US USD -30339000 7.16M
Cytokinetics CYTK:US USD -137380000 4.93M
Eli Lilly And LLY:US USD 1.94B 486M
Esperion Therapeutics ESPR:US USD -55487000 370K
Halozyme Therapeutics HALO:US USD 57.7M 3.93M
Immunogen IMGN:US USD -59008000 18.75M
Intercept Pharmaceuticals ICPT:US USD -20825000 288.28M
Intra Cellular Therapies ITCI:US USD -44026000 9.48M
Intrexon XON:US USD -22176000 109.56M
IONIS PHARMACEUT IONS:US USD -52430000 5.44M
JAZZ PHA JAZZ:US USD -240724000 221.08M
Mannkind MNKD:US USD -17947000 3.51M
Minerva Neurosciences NERV:US USD -6726000 175K
Nektar Therapeutics NKTR:US USD -59688000 639K
Peregrine Pharmaceuticals PPHM:US USD 461K 1.62M
Pfizer PFE:US USD 5B 3.61B
Rigel Pharmaceuticals RIGL:US USD 1.4M 20.44M
United Therapeutics UTHR:US USD 132.1M 107.2M
Vanda Pharmaceuticals VNDA:US USD 6.86M 3.59M